MetLife Investment Management’s Oracle ORCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$69.4M Sell
471,999
-12,403
-3% -$2.02M 0.35% 36
2025
Q4
$94.4M Sell
484,402
-5,169
-1% -$1.23M 0.46% 25
2025
Q3
$138M Sell
489,571
-726
-0.1% -$185K 0.66% 17
2025
Q2
$107M Sell
490,297
-232
-0% -$37.5K 0.63% 17
2025
Q1
$68.6M Sell
490,529
-3,492
-0.7% -$569K 0.37% 32
2024
Q4
$82.3M Buy
494,021
+7,329
+2% +$1.3M 0.45% 27
2024
Q3
$82.9M Sell
486,692
-10,965
-2% -$1.59M 0.48% 26
2024
Q2
$70.3M Buy
497,657
+99,114
+25% +$12.3M 0.42% 33
2024
Q1
$50.1M Sell
398,543
-12,404
-3% -$1.42M 0.34% 40
2023
Q4
$43.3M Sell
410,947
-3,426
-0.8% -$374K 0.31% 45
2023
Q3
$43.9M Sell
414,373
-1,910
-0.5% -$221K 0.34% 41
2023
Q2
$49.6M Sell
416,283
-22,111
-5% -$2.29M 0.36% 40
2023
Q1
$40.7M Sell
438,394
-4,637
-1% -$407K 0.29% 53
2022
Q4
$36.2M Sell
443,031
-3,205
-0.7% -$244K 0.27% 60
2022
Q3
$27.3M Sell
446,236
-19,157
-4% -$1.4M 0.23% 79
2022
Q2
$32.5M Sell
465,393
-31,333
-6% -$2.29M 0.25% 67
2022
Q1
$41.1M Buy
496,726
+140,375
+39% +$11.4M 0.27% 64
2021
Q4
$31.1M Sell
356,351
-15,705
-4% -$1.47M 0.26% 64
2021
Q3
$32.4M Sell
372,056
-49,121
-12% -$4.34M 0.29% 59
2021
Q2
$32.8M Sell
421,177
-20,807
-5% -$1.63M 0.29% 63
2021
Q1
$31M Sell
441,984
-18,679
-4% -$1.21M 0.28% 64
2020
Q4
$29.8M Sell
460,663
-29,505
-6% -$1.76M 0.28% 62
2020
Q3
$29.3M Sell
490,168
-54,186
-10% -$3.08M 0.32% 59
2020
Q2
$30.1M Sell
544,354
-14,079
-3% -$746K 0.34% 51
2020
Q1
$27M Sell
558,433
-17,086
-3% -$882K 0.37% 51
2019
Q4
$30.5M Sell
575,519
-23,628
-4% -$1.3M 0.32% 60
2019
Q3
$33M Sell
599,147
-69,700
-10% -$3.85M 0.36% 47
2019
Q2
$38.1M Sell
668,847
-55,306
-8% -$2.99M 0.41% 39
2019
Q1
$38.9M Buy
724,153
+35,792
+5% +$1.82M 0.42% 40
2018
Q4
$31.1M Sell
688,361
-133,885
-16% -$6.42M 0.38% 47
2018
Q3
$42.4M Sell
822,246
-55,024
-6% -$2.67M 0.43% 36
2018
Q2
$38.7M Sell
877,270
-32,141
-4% -$1.48M 0.46% 34
2018
Q1
$41.6M Sell
909,411
-33,246
-4% -$1.65M 0.49% 35
2017
Q4
$44.6M Buy
+942,657
New +$46.2M 0.5% 34

Other funds holding ORCL

MetLife Investment Management's ORCL Position: Q1 2026 in Review

MetLife Investment Management reduced its Oracle (ORCL) stake by 2.6% in Q1 2026, selling an estimated $2.02M and leaving 471,999 shares worth $69.4M. The position accounts for 0.35% of the portfolio, ranked #36.

MetLife Investment Management first reported a position in ORCL in Q4 2017 and has held it in 34 quarters since. The position peaked at $138M in Q3 2025. 3,472 funds tracked by Wall St. Rank hold ORCL as of Q1 2026.

  • MetLife Investment Management held 471,999 shares of Oracle worth $69.4M as of Q1 2026.
  • MetLife Investment Management sold 12,403 Oracle shares in Q1 2026, an estimated $2.02M.
  • Oracle made up 0.35% of MetLife Investment Management's portfolio in Q1 2026, its #36 holding.
  • MetLife Investment Management first reported a position in Oracle in Q4 2017 and has held it in 34 quarters since.
  • MetLife Investment Management's Oracle position peaked at $138M in Q3 2025.
  • 3,472 funds tracked by Wall St. Rank held Oracle as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.